Currently, the EMA's human medicines committee (CHMP) carries out its assessment of new medicines or post-marketing label extensions using data from clinical summaries and information reported in ...
5mon
GlobalData on MSNEMA CHMP recommends label update to Novo Nordisk’s WegovyThe trials revealed that the benefits of Wegovy were consistent across demographic and clinical subgroups ... that the EU ...
of the European Medicines Agency (EMA) has adopted a positive opinion recommending authorization of a label extension for IXCHIQ ®, Valneva’s single-dose vaccine for the prevention of disease caused ...
The leading Merkel Cell Carcinoma Companies such as ImmunityBio, OncoSec Medical, Exelixis, 4SC, Kartos Therapeutics, Incyte ...
of the European Medicines Agency (EMA) has adopted a positive opinion recommending authorization of a label extension for IXCHIQ®, Valneva’s single-dose vaccine for the prevention of disease ...
Success in preclinical studies or earlier clinical trials ... U.S. FDA 11 Valneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ®, to EMA and Health Canada 12 CEPI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results